EGFRBi armed fresh PBMC

· University of Virginia

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EGFRBi armed fresh PBMC, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer [Phase 1, Phase 2]